From Tumor Biology to Therapeutic Design: Expert Insights from Vector Laboratories
Two Vector scientists were recently interviewed about glycosylation in cancer research and advances in bioconjugation for next-generation therapeutics.
Insights from our team
Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Let’s Talk Protein Glycosylation at Cancer Glyco-X
Vector Laboratories will be attending Cancer Glyco-X 2026 to discuss how the right tools reveal glyco-insights in cancer research. Product Manager Shuhui Chen and Sr. Field Application Scientist Sabrina Mateos will be representing Vector Laboratories... Read more
Glycans and Immune Checkpoints: Revealing Hidden Influences on Cancer Immunotherapy
Immune checkpoint therapy describes a class of antibody therapeutics for the treatment of cancer that target proteins that modulate immune responses. More than a dozen approved therapeutics target immune checkpoint proteins like PD-1, PD-L1, and... Read more
Congenital Disorders of Glycosylation: Advancing Diagnostics and Therapeutics Through Glycobiology
Looking Beyond Genes and Proteins Genomics has transformed how we identify disease, and proteomics has expanded how we understand function. But in Congenital Disorders of Glycosylation (CDGs), neither tells the full story. CDGs arise from... Read more
Vector’s Multiplexing IHC Solutions Featured in Biocompare
We’re excited to share that Vector Laboratories and VectaPlex™ Antibody Removal Kit were featured in the Biocompare article, “Traditional vs. Multiplex Immunohistochemistry.” The piece highlights the need for multiplexing in tissue analysis and outlines how... Read more
See You at the AACR Annual Meeting 2026
Join us at booth #603 to explore cancer detection, targeting, and biomarker research solutions powered by 50 years of expertise. At the AACR Annual Meeting 2026 in San Diego, Vector Laboratories is showcasing how its... Read more
A New Focus for Breast Cancer: Protein Glycosylation’s Emerging Role
Probing protein glycosylation uncovers new diagnostic and therapeutic avenues for breast cancer, one of the most common forms of cancer.
Advancing Colorectal Cancer Research with Biomarker-Driven Tools
As colorectal cancer research continues to shift toward precision approaches, the ability to accurately detect and characterize key biomarkers is more important than ever.
Glycosylation in the Alzheimer’s Brain: Visualizing New Paths to Diagnosis and Therapy
Alzheimer’s Disease is complex disease on the rise worldwide. Glycosylation is critical to every facet of disease mechanisms and treatments.
Meet Vector Labs at NextGen Omics 2026
Join us at booth #21 to explore solutions across spatial analysis, single cell proteomics, and biomarker discovery. This year, Vector Labs is highlighting new approaches to protein glycosylation and spatial biology, alongside our broader portfolio... Read more
